<DOC>
	<DOCNO>NCT00531297</DOCNO>
	<brief_summary>Any effort spare patient T1 carcinomas rectum low anterior resection even abdominoperineal resection link risk locoregional recurrence 10 % ( range , 0-24 ) . This tolerated view morbidity mortality risk relate transabdominal resection , high 7-68 % 0-6.5 % , respectively . Accordingly , addition transanal local excision various adjuvant therapy scheme chemo- and/or radiotherapy develop , give uncertainty lymph node stage . Another approach identify histological risk criterion primary tumor term define limit rectum-sparing therapy . In early experimental clinical study investigator research applied dorsoposterior extraperitoneal pelviscopy , i.e . perineal access soft-tissue area minor pelvis use minimally invasive surgery . T1 carcinoma rectum technique become significant , perineal approach make possible perform endoscopic posterior mesorectal resection ( EPMR ) combination rectum-sparing surgery Thereby relevant lymphatic field lower rectum remove histologically examine . As consequence EPMR low loco-regional recurrence rate , since common cause pre-existent far detectable lymph node metastasis besides incomplete resection primary tumor .</brief_summary>
	<brief_title>Endoscopic Posterior Mesorectal Resection T1 Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Stage T1 ( ) Over 18 year old Patient 's consent Previous R0 resection rectal tumor Metastases ( M1 ) Neoadjuvant chemotherapy radiotherapy Meta synchronous tumor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>